Hurt H, Brodsky N L, Braitman L E, Giannetta J
Division of Neonatology, Albert Einstein Medical Center, Temple University School of Medicine, Philadelphia, Pa. 19141, USA.
J Perinatol. 1995 Jul-Aug;15(4):297-304.
Cocaine use by pregnant women has increased dramatically in recent years. To assess the effect of maternal cocaine use on infant outcome, we enrolled 224 women (105 cocaine users, 119 control subjects) and their infants (all of 34 weeks or more gestational age and nonasphyxiated) in a prospective, blinded study. Results showed that infants exposed to cocaine were more likely to be admitted to the newborn intensive care unit, be treated for congenital syphilis, have a greater length of stay, and be discharged to a person other than the mother (all p < 0.01). Birth weight and head circumference, adjusted for gestational age, were smaller in the infants exposed to cocaine than in control infants (p < 0.001). After statistically controlling for cigarette use and other confounders, however, the odds of infants exposed to cocaine and control infants having birth weight and head circumferences less than the 25th percentile for gestational age did not differ (both p > 0.80). Infants of cocaine-using mothers and control subjects had a similar incidence of abnormal cranial and renal ultrasonographic findings and abnormal pneumocardiograms (all p > or = 0.32). We conclude that in this cohort of nonasphyxiated infants of 34 weeks or more gestational age, infants exposed to cocaine had more medical and social problems than control infants but did not differ statistically in the incidence of severe growth retardation, abnormal cranial or renal ultrasonographic findings, or abnormal pneumocardiograms. We suggest that natal interventions for the nonasphyxiated term and near-term infant exposed to cocaine should include a careful history and physical examination, follow-up plans, and social service involvement.
近年来,孕妇使用可卡因的情况急剧增加。为评估孕妇使用可卡因对婴儿结局的影响,我们开展了一项前瞻性、盲法研究,纳入了224名女性(105名可卡因使用者,119名对照对象)及其婴儿(均为孕龄34周及以上且无窒息情况)。结果显示,接触可卡因的婴儿更有可能被收治入新生儿重症监护病房、接受先天性梅毒治疗、住院时间更长,且出院后由母亲以外的人照顾(所有p<0.01)。校正孕龄后,接触可卡因的婴儿出生体重和头围小于对照婴儿(p<0.001)。然而,在对吸烟情况及其他混杂因素进行统计学控制后,接触可卡因的婴儿与对照婴儿出生体重和头围低于孕龄第25百分位数的几率并无差异(均p>0.80)。使用可卡因的母亲的婴儿与对照对象的婴儿在头颅和肾脏超声检查异常结果及心电图异常方面的发生率相似(均p≥0.32)。我们得出结论,在这一孕龄34周及以上无窒息婴儿队列中,接触可卡因的婴儿比对照婴儿存在更多医疗和社会问题,但在严重生长发育迟缓、头颅或肾脏超声检查异常结果或心电图异常的发生率方面并无统计学差异。我们建议,对于接触可卡因的足月及近足月无窒息婴儿,出生时的干预措施应包括详细的病史和体格检查、随访计划以及社会服务介入。